Federal Judge Blocks Trump Administration's Vaccine Schedule Revisions and Committee Appointments
A federal judge has temporarily blocked the Trump administration's recent revisions to the US childhood vaccine schedule and invalidated the appointments of new members to the CDC's Advisory Committee on Immunization Practices (ACIP). The ruling cited violations of federal law and established scientific procedures, following lawsuits from multiple medical associations.
The federal judge's ruling effectively halted the administration's plan to reduce the number of universally recommended childhood immunizations from 17 to 11. The decision also challenged the process by which these changes were implemented and the composition of the key advisory committee.
Revised Vaccine Schedule Announced
In January, federal health officials announced an immediate revision to the routine childhood vaccine recommendations, decreasing the number of universally recommended immunizations from 17 to 11. This move, overseen by HHS Secretary Robert F. Kennedy Jr. and authorized by acting CDC Director Jim O’Neill, stemmed from a December directive by President Donald Trump to review the immunization schedule and align US recommendations with those of "peer, developed countries."
Under the updated guidelines, specific vaccines were categorized:
- Universally Recommended Vaccines: Diphtheria, tetanus, pertussis, Haemophilus influenzae type B (Hib), pneumococcal disease, polio, measles, mumps, rubella, human papillomavirus (HPV) (single dose instead of two or three), and varicella (chickenpox).
- High-Risk Individuals Only: Vaccines for hepatitis A, hepatitis B, Respiratory Syncytial Virus (RSV), dengue, meningococcal ACWY, and meningococcus B. The initial announcement did not clarify the definition of "high-risk individual."
- Shared Clinical Decision-Making: Vaccines for rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B. This category typically requires a discussion between the patient/family and a healthcare provider.
Officials justified the changes by stating they aimed to align the US schedule with international consensus, particularly Denmark's protocol, and to enhance public trust. The administration also indicated that these revised vaccines would continue to be covered by federal programs like Vaccines for Children and private health insurance.
Departure from Standard Process and Expert Concerns
The revisions were implemented without the traditional process involving public consideration of scientific evidence and input from outside experts, including the Advisory Committee on Immunization Practices (ACIP). Critics pointed out that the standard procedure typically includes public meetings with opportunities for comments from scientific experts and professional organizations.
Medical and public health experts expressed significant concerns regarding the revised schedule:
- Public Health Impact: Experts like infectious diseases physician Paul Offit and virologist James Alwine warned that the changes could lead to increased spread of previously controlled viruses and bacteria, resulting in more diseases, hospitalizations, and deaths.
- Procedural Integrity: Dr. Jason M. Goldman, president of the American College of Physicians, emphatically stated: "Abandoning the U.S. evidence-based process is a dangerous and potentially deadly decision." Former CDC and FDA officials highlighted the lack of transparency, public input, or data supporting the changes.
- Confusion and Access: Vaccine law expert Dorit Reiss and Dr. Ronald Nahass, President of the Infectious Diseases Society of America, suggested the changes could create confusion among healthcare providers and parents, potentially decreasing vaccine coverage and posing operational challenges for doctors.
- Data Collection: Concerns were further raised by a study in Annals of Internal Medicine, which indicated that nearly half of the CDC's public health databases, especially those related to vaccinations, were paused without explanation after March and April 2025.
International Comparisons and Rationale
The administration's justification included aligning the US schedule with "peer, developed countries," specifically citing Denmark as a model. However, many experts countered that Denmark's schedule is an outlier compared to most other high-income nations. Countries like the UK, Canada, Australia, Japan, and European nations generally maintain vaccine schedules similar to the former US recommendations, typically recommending 13 to 16 vaccines for all children.
Experts highlighted significant differences between the US and Denmark, including Denmark's universal healthcare, reliable prenatal care, consistent medical follow-up, and a national health registry—factors largely absent in the decentralized US healthcare system. Japan's historical experience with reducing or discontinuing vaccine recommendations was cited as an example where such changes led to declines in vaccination rates and increases in disease transmission and deaths.
ACIP Reconstitution and Leadership Views
In June 2025, Secretary Kennedy dismissed all 17 existing members of the ACIP and appointed new advisors. Many of these new appointees, including ACIP chair Kirk Milhoan, have publicly expressed views critical of established vaccine science.
Milhoan, a pediatric cardiologist appointed in December, stated in a podcast interview that the committee's objective is to prioritize "individual autonomy" over public health. He questioned established vaccine science, suggesting that modern sanitation alone could control diseases like polio and measles without vaccines and proposing a re-evaluation of long-settled vaccine recommendations. Under the reconstituted ACIP, members had voted to:
- Weaken universal hepatitis B vaccination recommendations for newborns.
- End recommendations for certain flu vaccines containing thimerosal.
- End the recommendation for the combination measles, mumps, rubella, and varicella (MMRV) vaccine.
Federal Judge Blocks Policy Changes and Committee Appointments
On February 13, US District Judge Brian E. Murphy issued a ruling that temporarily blocked the new vaccine schedule and invalidated the appointments of new ACIP members.
The judge's ruling addressed two main areas:
- Vaccine Schedule Blocked: The CDC's January decision to revise the US childhood vaccine schedule was found not to adhere to proper legal channels, with the judge deeming it "arbitrary and capricious."
- ACIP Appointments Invalidated: Judge Murphy ruled that Secretary Kennedy's dismissal of previous ACIP members and appointment of new ones violated the Federal Advisory Committee Act (FACA). This act mandates that government committees requiring technical expertise include individuals with relevant professional qualifications. The appointments of 13 new members were stayed, effectively invalidating their roles and all votes taken by them over the past year.
- Meeting Postponed: Following the ruling, the ACIP's scheduled meeting for late February was postponed.
The ruling stated that the government "disregarded those methods and thereby undermined the integrity of its actions" by not following scientific and legally codified procedures.
The lawsuit was brought by several medical associations, including the American Academy of Pediatrics (AAP), who argued that the changes bypassed evidence-based recommendations. HHS spokesperson Andrew Nixon stated that the department anticipates the judge's decision will be overturned and confirmed plans to appeal the ruling.
Implications and State Responses
The AAP, which represents a majority of pediatricians, released its own immunization guidelines recommending routine vaccination against 18 diseases, aligning with the CDC's recommendations prior to the recent changes. Several states, including California, New York, Illinois, Maryland, and Oregon, have indicated they will continue to follow established guidelines or those from the AAP, independent of the federal revisions. This creates a potential for a varied landscape of vaccine regulations and confusion across states.